RHONE-POULENC RORER S.A.
Patent Owner
Stats
- 12 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 20, 2005 most recent publication
Details
- 12 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 996 Total Citation Count
- Apr 03, 1989 Earliest Filing
- 87 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6977174 Circular DNA molecule with conditional origin of replication, method for preparing the same and use thereof in gene therapySep 13, 96Dec 20, 05[C12N]
6180359 Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilaseOct 24, 97Jan 30, 01[C12P, C12N]
5912365 Derivatives of 2-azabicyclo?2.2.1! heptane, their preparation and their applicationAug 19, 97Jun 15, 99[C07D]
5691163 Cells with altered betaine catabolism and their use in producing metabolites or enzymesMay 18, 95Nov 25, 97[C12P, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2005/0069,523 Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)AbandonedJul 09, 03Mar 31, 05[A61K, C12N]
6852509 Anti-P53 single-chain antibody fragments and their usesExpiredApr 26, 99Feb 08, 05[C07H, C12P, C12N, C07K]
2004/0009,592 Genetically-modified neural progenitors and uses thereofAbandonedNov 27, 02Jan 15, 04[C12N]
2003/0082,150 RECOMBINANT ADENOVIRAL VECTORS FOR HUMAN TUMOUR GENE THERAPYAbandonedOct 05, 98May 01, 03[A61K, C12N]
2003/0060,432 ANTAGONISTS OF THE ONCOGENIC ACTIVITY OF THE PROTEIN MDM2, AND USE THEREOF IN THE TREATMENT OF CANCERSAbandonedMar 23, 98Mar 27, 03[A61K]
2003/0004,091 MEDICINAL COMBINATION USEFUL FOR IN VIVO EXOGENIC TRANSFECTION AND EXPRESSIONAbandonedMay 22, 98Jan 02, 03[A61K, C12N]
2002/0006,660 GENETICALLY-MODIFIED NEURAL PROGENITORS AND USES THEREOFAbandonedFeb 28, 97Jan 17, 02[A61K, C12N]
6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereofExpiredSep 12, 96Mar 07, 00[A01N, C12P, C12N]
6017966 Stabilized pharmaceutical compositions containing dobutamineExpiredApr 24, 98Jan 25, 00[A61K]
5948755 Cyclosporin compound, its preparation and the pharmaceutical compositions which contain itExpiredDec 23, 97Sep 07, 99[A61K, C07K]
5889053 Farnesyl transferase inhibitors, preparation thereof and pharmaceuticals compositions containing said inhibitorsExpiredJan 09, 98Mar 30, 99[A61K]
5861529 Farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain themExpiredJun 18, 97Jan 19, 99[A01N, C07C]
5856439 Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing sameExpiredAug 01, 97Jan 05, 99[A61K]
5849724 Microorganism of genus chrysosporium for use in preparing farnesyl transferase inhibitorsExpiredAug 08, 97Dec 15, 98[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.